Skip to main content
TipRanks
Go Ultimate75% OFF

Charles Sherwood Insider Profile

4 Followers

Charles Sherwood, CEO and Director, Director at Anika Therapeutics, holds 189.89K shares in Anika Therapeutics (Ticker: ANIK).

Charles Sherwood's Trading History

ANIK
Anika Therapeutics
Jan 26, 2018CEO and Director, DirectorUninformative Buy―$2.45M
ANIK
Insider Shares: 189.89K (1.30%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Jan 26, 2018Uninformative Buy$0.0057,100$0.00―
Oct 26, 2017Uninformative Sell$196.81K3,278$60.04―
Oct 24, 2017Uninformative Sell$1.69M28,219$60.05―
Oct 18, 2017Uninformative Sell$197.71K3,293$60.04―
Oct 16, 2017Uninformative Sell$428.01K7,124$60.08―

You May Also Like

Charles Sherwood insider profile FAQ

What is the percentage of profitable transactions made by Charles Sherwood?
The percentage of profitable transactions made by Charles Sherwood is 0%.
What is the average return per transaction made by Charles Sherwood?
The average return per transaction made by Charles Sherwood is -12.20%.
What stocks does Charles Sherwood hold?
Charles Sherwood holds: ANIK stocks.
What was Charles Sherwood's most profitable transaction?
Charles Sherwood’s most profitable transaction was an Informative Sell of ANIK stock on May 2, 2014. The return on the trade was -1.40%.
What is Charles Sherwood's role in Anika Therapeutics?
Charles Sherwood's role in Anika Therapeutics is CEO and Director, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.